Skip to content
10-K

Annual Report

Orthofix Medical Inc. OFIX

0001193125-26-065189

← back to feed
Filed
Feb 24, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 20, 2026 40.14M sh
Shares Diluted FY 2025 · Dec 31, 2025 39.6M sh
Shares Diluted FY 2025 · Dec 31, 2024 38.13M sh
Shares Diluted FY 2025 · Dec 31, 2023 36.73M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 $33.35M
Operating Cash Flow FY 2025 · Dec 31, 2024 $25.79M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$45.75M
Long Term Debt FY 2025 · Dec 31, 2025 $157.39M
Long Term Debt FY 2025 · Dec 31, 2024 $157.02M
Short Term Debt FY 2025 · Dec 31, 2025 $0
Short Term Debt FY 2025 · Dec 31, 2024 $0
Cash And Equivalents FY 2025 · Dec 31, 2025 $82.03M
Cash And Equivalents FY 2025 · Dec 31, 2024 $83.24M
Cash And Equivalents FY 2025 · Dec 31, 2023 $33.11M
Stockholders Equity FY 2025 · Dec 31, 2025 $450.04M
Stockholders Equity FY 2025 · Dec 31, 2024 $503.12M
Stockholders Equity FY 2025 · Dec 31, 2023 $598.73M
Stockholders Equity FY 2025 · Dec 31, 2022 $336.86M
Current Liabilities FY 2025 · Dec 31, 2025 $170.48M
Current Liabilities FY 2025 · Dec 31, 2024 $168.63M
Total Liabilities FY 2025 · Dec 31, 2025 $400.61M
Total Liabilities FY 2025 · Dec 31, 2024 $390.17M
Current Assets FY 2025 · Dec 31, 2025 $416.85M
Current Assets FY 2025 · Dec 31, 2024 $433.29M
Total Assets FY 2025 · Dec 31, 2025 $850.65M
Total Assets FY 2025 · Dec 31, 2024 $893.29M
Eps Diluted FY 2025 · Dec 31, 2025 −$2.33
Eps Diluted FY 2025 · Dec 31, 2024 −$3.30
Eps Diluted FY 2025 · Dec 31, 2023 −$4.12
Eps Basic FY 2025 · Dec 31, 2025 −$2.33
Eps Basic FY 2025 · Dec 31, 2024 −$3.30
Eps Basic FY 2025 · Dec 31, 2023 −$4.12
Sga Expense FY 2025 · Dec 31, 2025 $554.33M
Sga Expense FY 2025 · Dec 31, 2024 $532.53M
Sga Expense FY 2025 · Dec 31, 2023 $530.4M
Rd Expense FY 2025 · Dec 31, 2025 $65.85M
Rd Expense FY 2025 · Dec 31, 2024 $73.64M
Rd Expense FY 2025 · Dec 31, 2023 $80.23M
Net Income FY 2025 · Dec 31, 2025 −$92.19M
Net Income FY 2025 · Dec 31, 2024 −$126M
Net Income FY 2025 · Dec 31, 2023 −$151.4M
Operating Income FY 2025 · Dec 31, 2025 −$81.43M
Operating Income FY 2025 · Dec 31, 2024 −$84.62M
Operating Income FY 2025 · Dec 31, 2023 −$139.11M
Gross Profit FY 2025 · Dec 31, 2025 $566.02M
Gross Profit FY 2025 · Dec 31, 2024 $545.89M
Gross Profit FY 2025 · Dec 31, 2023 $486.27M
Cost Of Revenue FY 2025 · Dec 31, 2025 $256.3M
Cost Of Revenue FY 2025 · Dec 31, 2024 $253.61M
Cost Of Revenue FY 2025 · Dec 31, 2023 $260.37M
Revenue FY 2025 · Dec 31, 2025 $822.31M
Revenue FY 2025 · Dec 31, 2024 $799.49M
Revenue FY 2025 · Dec 31, 2023 $746.64M